Sarconeos BIO101 in development for the treatment of Sarcopenia by Biophytis
Yahoo! finance - 27-Jun-2022SARA-INT Phase 2 study and SARA Phase 3 study milestones in developing sarconeos
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
CEO and Founder of Biophytis
Stanislas Veillet created Biophytis in September 2006. He previously held a number of positions in the fields of medical research, nutrition and functional foods, in particular with Danone, Pharmacia-Monsanto and Cargill. Stanislas has a doctorate in genetics, graduated in engineering from AgroParisTech and has authored a dozen patents.
Company focused on development of therapeutics that slow the degenerative processes associated with aging.
Details last updated 06-Jul-2022
SARA-INT Phase 2 study and SARA Phase 3 study milestones in developing sarconeos